Search for content and authors
 

Searching for lead molecules as potential new CNS agents in the serotonin 5-HT6 screening assay

Beata Duszyńska 1,  Andrzej J. Bojarski 1,  Jan Boksa 1,  Tomasz Lenda 1,  Dorota Kamińska 1,  Marcin Cybulski 2,  Łukasz S. Kaczmarek 2

1. Polish Academy of Sciences. Institute of Pharmacology, Smętna 12, Kraków 31-343, Poland
2. Pharmaceutical Research Institute (IF), Rydygiera 8, Warszawa 01-793, Poland

Abstract
Among 14 different serotonin receptor subtypes 5-HT6 and 5-HT7 ones, simultaneously discovered in 1993, are classified as last members in 5-HT receptor superfamily. They both show high affinity for a wide range of agents used in psychiatry, and many drug discovery programs have been initiated, which were focused on the search of selective 5-HT6 and/or 5-HT7 ligands. In the filed of serotonergics we have successfully concentrated on the development of compounds active at 5-HT1A, 5-HT2A and 5-HT7 receptors and recently our studies were extend on 5-HT6 ligands. Strategy that was previously elaborated for investigations of 5-HT7 receptors was applied and both an in-house and external compounds libraries were screened in 5-HT6 receptor binding assay. Several lead molecules have been identified for further structure optimization on the basis of 5-HT6 receptor homology model.

This study was partly supported by the Network "Synthesis, structure and therapeutic properties of compounds and organic substances" coordinated by the Institute of Organic Chemistry Polish Academy of Sciences.

 

Legal notice
  • Legal notice:

    Copyright (c) Pielaszek Research, all rights reserved.
    The above materials, including auxiliary resources, are subject to Publisher's copyright and the Author(s) intellectual rights. Without limiting Author(s) rights under respective Copyright Transfer Agreement, no part of the above documents may be reproduced without the express written permission of Pielaszek Research, the Publisher. Express permission from the Author(s) is required to use the above materials for academic purposes, such as lectures or scientific presentations.
    In every case, proper references including Author(s) name(s) and URL of this webpage: https://science24.com/paper/14801 must be provided.

 

Related papers
  1. Ethical and generic drugs
  2. Synthesis of new 5H-indolo[2,3-b]quinoline derivatives with a high selective cytotoxic activity
  3. Determination of organic volatile impurities in Nepafenac by GC method
  4. Serotonin transporter inhibitors inducing hypothermia at mice
  5. Rational design and synthesis of new 5-HT6R ligands with the use of bioisosteric strategies. Crystal structures, biological evaluation and molecular modeling studies.
  6. Evaluation of potential genotoxic impurities in prasugrel intermediate by HPLC chromatography
  7. Simultaneous CE determination of counterion and possible impurity from synthetic route in pharmaceutical substance prasugrel hydrochloride.
  8. Ligand-directed receptor trafficking
  9. 5H-indolo-[2,3-b]quinolines loaded polymeric micelles
  10. Efficient preparation of a key intermediate in the exemestane synthesis
  11. Synthesis, anticonvulsant activity and 5-HT1A/5-HT7 receptors affinity of new 1-[(4-substituted-  piperazin-1-yl)-alkyl]- 3-methyl- 3-(2-methylpropyl)-pyrrolidine- 2,5-diones
  12. The multiobjective based design, synthesis and evaluation of the arylsulfonamide/amide derivatives of arylxyethyl- and arylthioethyl- piperidines and pyrrolidines as a novel class of potent 5-HT7 receptor antagonists
  13. Synthesis and biological evaluation of new amino acid and dipeptide derivatives of neocryptolepine as anticancer agents. 
  14. Determination of reaction progress in synthesis of EE-3 by NMR technique
  15. Optimization of BR-8 synthesis
  16. Homology modeling of G-protein coupled receptors
  17. Identification of Novel 5-HT7R Ligands via Multistep Virtual Screening of Commercially Available Compounds Databases
  18. Examination of 5-HT6 receptor affinity in the group of arylsulfonamide derivatives
  19. Interaction fingerprints patterns. Binding mode analysis of mGlu2 receptor model based on docking studies
  20. Quinolinesulfonamides as potential 5-HT7 and 5-HT1A receptor ligands
  21. Alkyl-nitroquipazine derivatives as serotonin transporter and 5-HT1A receptor ligands
  22. CHO cell line with stable expression of the HTRA1 gene as a tool for studying functional activity of 5-HT1A receptor ligands
  23. Synthesis of long-chain arylpiperazine theophylline derivatives as potential 5-HT7 and 5-HT6 receptors ligands
  24. Exploration of sugar-based inhibitors of glycolysis to target brain tumors
  25. New amino acid and peptide derivatives of 5H-indolo[2,3-b]quinoline and their biological activity.
  26. The evaluation of tolterodine tartrate synthesis based on patent EP 0 325 574 B1.
  27. HPLC as a method for analytical control of synthesis and determination of tolterodine (TD-S)
  28. Flexible vs partly constrained linkers in NAN-190 and PK-13 analogs investigated as 5-HT1A/5-HT7 receptor ligands
  29. Mannich bases, 5-arylimidazolidine-2,4-dione derivatives with arylpiperazine moiety, as 5-HT1A receptor ligands with serotonin transporter affinity
  30. Crystal structure of β-adrenergic receptor as a new template in homology modeling of GPCR. Application to serotonin 5-HT1A and 5-HT7 receptors
  31. Solid-phase synthesis and preliminary biological investigation of arylpiperazine library as 5-HT1A and 5-HT2A receptor ligands
  32. 2-(1-Arylsulfonylpiperidin-2-yl)ethyl derivatives as 5-HT7 receptor ligands: synthesis and their affinity for 5-HT1A/5-HT2A/5-HT7/D2 receptors
  33. SAR studies of novel 5-HT7R ligands with different spacers between aryl and amine moieties
  34. Synthesis of novel pyrido[1,2-c]pyrimidine derivatives as selective ligands for 5-HT1A receptors
  35. New serotonin receptors ligands in the group of 8-acylamide derivatives of 1,3-dimethyl-7-[(4-phenyl- piperazin-1-yl)-alkyl]-1H-purine-2,6-(3H,7H)-dione
  36. Synthesis and serotonin receptors activity of new purine-2,6-dione derivatives with arylpiperazinylalkoxy moieties
  37. Molecular modeling explains differences in binding affinity of new potent and selective 5-HT1A ligands: arylpiperazinylalkylthiobenzoxazole derivatives
  38. New amino acid derivatives of 6H-indolo[2,3-b]quinolines
  39. The ligand binding to the serotonin transporter
  40. NEW DUAL 5-HT7/5-HT1A LIGANDS WITH ANTIDEPRESSANT AND ANXIOLYTIC-LIKE ACTIVITY
  41. STRUCTURAL MODIFICATIONS OF SOME ARYLPIPERAZINE LIGANDS TOWARDS IMPROVED SELECTIVITY FOR 5-HT7 RECEPTORS
  42. THE BIOLOGICAL TARGET DERIVED PHARMACOPHORIC MODEL FOR 5-HT7 SEROTONIN RECEPTOR ANTAGONISM
  43. 8-ALKOXY-PURINE-2,6-DIONES WITH 7-PHENYLPIPERAZINYLALKYL AND 7-TETRAHYDRO-ISOQUINOLINYLALKYL MOIETIES AS 5-HT1A, 5-HT2A, 5-HT7 RECEPTOR LIGANDS
  44. DESIGN AND SYNTHESIS OF NEW 7-PHENYLPIPERAZINYLALKYL AND 7-TETRAHYDROISOQUINOLINYLALKYL DERIVATIVES OF PURINE-2,6,8-TRIONE AS POTENTIAL SEROTONIN RECEPTOR AGENTS

Presentation: Poster at VI Multidyscyplinarna Konferencja Nauki o Leku, by Andrzej J. Bojarski
See On-line Journal of VI Multidyscyplinarna Konferencja Nauki o Leku

Submitted: 2008-03-15 23:35
Revised:   2009-06-07 00:48